Abstract
Carpal tunnel syndrome (CTS) is a common peripheral mononeuropathy affecting up to 4% of the general population, typically women in late middle age. The incidence in patients with Fabry disease (FD) is unclear, but may affect 25% of patients with this X-linked lysosomal storage disease. We report three cases of CTS in young Caucasian male patients with classical FD, who developed CTS symptoms with supportive nerve conduction study (NCS) findings. Two patients had bilateral CTS and two had evidence of concurrent ulnar nerve neuropathy on NCS, suggesting a systemic process contributed to nerve compression. All were receiving enzyme replacement therapy (ERT) and had a moderate burden of FD complications. It is possible that an increase in connective tissue in the intracarpal canal in FD patients may be incited by injury to fibroblasts, via either accumulation of globotriaosylceramide (GL3) or local ischaemia through endothelial injury. The former hypothesis may be a more plausible explanation for the development of CTS, as histology of the flexor retinaculae from our patients has demonstrated fibroblasts with characteristic vacuolation and excessive myxomatous stroma, despite endothelial clearance of GL3 in these patients receiving ERT. CTS should not be overlooked in FD patients and young patients presenting with CTS should be evaluated for an underlying systemic or genetic disorder. Surgical carpal tunnel decompression was effective in our patients, already troubled by long-standing acroparesthesia, in providing sustained relief of symptoms.
Competing interests: None declared.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Askari H, Kaneski CR, Semino-Mora C, Desai P, Ang A, Kleiner DE, Perlee LT, Quezado M, Spollen LE, Wustman BA, Schiffmann R (2007) Cellular and tissue localization of globotriaosylceramide in Fabry disease. Virchows Arch 451(4):823–834
Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Rosen I (1999) Prevalence of carpal tunnel syndrome in a general population. JAMA 282(2):153–158
Beck M (2006) The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Paediatr Suppl 95(451):43–46
Bland JD (2000) A neurophysiological grading scale for carpal tunnel syndrome. Muscle Nerve 23(8):1280–1283
Charles J, Fahridin S, Britt H (2009) Carpal tunnel syndrome. Aust Fam Physician 38(9):665
Elleder M (2003) Sequelae of storage in Fabry disease – pathology and comparison with other lysosomal storage diseases. Acta Paediatr Suppl 92(443):46–53, discussion 45
Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001) Safety and efficacy of recombinant human alpha-galactosidase A–replacement therapy in Fabry's disease. N Engl J Med 345(1):9–16
Galanos J, Nicholls K, Grigg L, Kiers L, Crawford A, Becker G (2002) Clinical features of Fabry's disease in Australian patients. Intern Med J 32(12):575–584
Gelberman RH, Hergenroeder PT, Hargens AR, Lundborg GN, Akeson WH (1981) The carpal tunnel syndrome. A study of carpal canal pressures. J Bone Joint Surg Am 63(3):380–383
Hakim AJ, Cherkas L, El Zayat S, MacGregor AJ, Spector TD (2002) The genetic contribution to carpal tunnel syndrome in women: a twin study. Arthritis Rheum 47(3):275–279
Hasholt L, Wandall A, Sorensen SA (1988) Enzyme replacement in Fabry endothelial cells and fibroblasts: uptake experiments and electron microscopical studies. Clin Genet 33(5):360–371
Hilz MJ, Stemper B, Kolodny EH (2000) Lower limb cold exposure induces pain and prolonged small fiber dysfunction in Fabry patients. Pain 84(2–3):361–365
Hilz MJ, Brys M, Marthol H, Stemper B, Dutsch M (2004) Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy. Neurology 62(7):1066–1072
Kawashima I, Watabe K, Tajima Y, Fukushige T, Kanzaki T, Kanekura T, Sugawara K, Ohyanagi N, Suzuki T, Togawa T, Sakuraba H (2007) Establishment of immortalized Schwann cells from Fabry mice and their low uptake of recombinant alpha-galactosidase. J Hum Genet 52(12):1018–1025
Kaye EM, Kolodny EH, Logigian EL, Ullman MD (1988) Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation. Ann Neurol 23(5):505–509
Keslova-Veselikova J, Hulkova H, Dobrovolny R, Asfaw B, Poupetova H, Berna L, Sikora J, Golan L, Ledvinova J, Elleder M (2008) Replacement of alpha-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients. Virchows Arch 452(6):651–665
Kocen RS, Thomas PK (1970) Peripheral nerve involvement in Fabry's disease. Arch Neurol 22(1):81–88
Laaksonen SM, Roytta M, Jaaskelainen SK, Kantola I, Penttinen M, Falck B (2008) Neuropathic symptoms and findings in women with Fabry disease. Clin Neurophysiol 119(6):1365–1372
Lozano-Calderon S, Anthony S, Ring D (2008) The quality and strength of evidence for etiology: example of carpal tunnel syndrome. J Hand Surg Am 33(4):525–538
Luciano CA, Russell JW, Banerjee TK, Quirk JM, Scott LJ, Dambrosia JM, Barton NW, Schiffmann R (2002) Physiological characterization of neuropathy in Fabry's disease. Muscle Nerve 26(5):622–629
Mattioli S, Baldasseroni A, Bovenzi M, Curti S, Cooke RM, Campo G, Barbieri PG, Ghersi R, Broccoli M, Cancellieri MP, Colao AM, Dell'omo M, Fateh-Moghadam P, Franceschini F, Fucksia S, Galli P, Gobba F, Lucchini R, Mandes A, Marras T, Sgarrella C, Borghesi S, Fierro M, Zanardi F, Mancini G, Violante FS (2009) Risk factors for operated carpal tunnel syndrome: a multicenter population-based case-control study. BMC Public Health 9:343
Mayes JS, Cray EL, Dell VA, Scheerer JB, Sifers RN (1982) Endocytosis of lysosomal alpha-galactosidase A by cultured fibroblasts from patients with Fabry disease. Am J Hum Genet 34(4):602–610
Murray GJ, Anver MR, Kennedy MA, Quirk JM, Schiffmann R (2007) Cellular and tissue distribution of intravenously administered agalsidase alfa. Mol Genet Metab 90(3):307–312
Schiffmann R (2006) Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy. Acta Neurol Belg 106(2):61–65
Sima AA, Robertson DM (1978) Involvement of peripheral nerve and muscle in Fabry's disease. Histologic, ultrastructural, and morphometric studies. Arch Neurol 35(5):291–301
Sri-Ram K, Vellodi A, Pitt M, Eastwood DM (2007) Carpal tunnel syndrome in lysosomal storage disorders: simple decompression or external neurolysis? J Pediatr Orthop B 16(3):225–228
Thurberg BL, Fallon JT, Mitchell R, Aretz T, Gordon RE, O'Callaghan MW (2009) Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy. Circulation 119(19):2561–2567
Torvin Moller A, Winther Bach F, Feldt-Rasmussen U, Rasmussen A, Hasholt L, Lan H, Sommer C, Kolvraa S, Ballegaard M, Staehelin Jensen T (2009) Functional and structural nerve fiber findings in heterozygote patients with Fabry disease. Pain 145(1–2):237–245
Toyooka K, Said G (1997) Nerve biopsy findings in hemizygous and heterozygous patients with Fabry's disease. J Neurol 244(7):464–468
Uchiyama S, Itsubo T, Nakamura K, Kato H, Yasutomi T, Momose T (2010) Current concepts of carpal tunnel syndrome: pathophysiology, treatment, and evaluation. J Orthop Sci 15(1):1–13
Van Meir N, De Smet L (2003) Carpal tunnel syndrome in children. Acta Orthop Belg 69(5):387–395
Werner RA, Andary M (2002) Carpal tunnel syndrome: pathophysiology and clinical neurophysiology. Clin Neurophysiol 113(9):1373–1381
Wilcox WR, Banikazemi M, Guffon N, Waldek S, Lee P, Linthorst GE, Desnick RJ, Germain DP (2004) Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am J Hum Genet 75(1):65–74
Yuen A, Dowling G, Johnstone B, Kornberg A, Coombs C (2007) Carpal tunnel syndrome in children with mucopolysaccaridoses. J Child Neurol 22(3):260–263
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Robin Lachmann.
Synopsis
Synopsis
Carpal tunnel syndrome may be a sequela of classical Fabry Disease (through injury to fibroblasts or local ischaemia within the carpal tunnel) despite long-term enzyme replacement therapy, and effective relief of symptoms can be achieved with surgical decompression.
Rights and permissions
Copyright information
© 2011 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ghali, J., Murugasu, A., Day, T., Nicholls, K. (2011). Carpal Tunnel Syndrome in Fabry Disease. In: JIMD Reports - Case and Research Reports, 2011/2. JIMD Reports, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2011_37
Download citation
DOI: https://doi.org/10.1007/8904_2011_37
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-24757-6
Online ISBN: 978-3-642-24758-3
eBook Packages: MedicineMedicine (R0)